Chalmers KA - Search Results

1

Cholinesterase inhibitors may increase phosphorylated tau in Alzheimer's disease.

Chalmers KA, Wilcock GK, Vinters HV, Perry EK, Perry R, Ballard CG, Love S. Chalmers KA, et al. J Neurol. 2009 May;256(5):717-20. doi: 10.1007/s00415-009-5000-2. Epub 2009 Feb 25. J Neurol. 2009. PMID: 19240967 Free PMC article.

2

Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism.

Katzov H, Chalmers K, Palmgren J, Andreasen N, Johansson B, Cairns NJ, Gatz M, Wilcock GK, Love S, Pedersen NL, Brookes AJ, Blennow K, Kehoe PG, Prince JA. Katzov H, et al. Hum Mutat. 2004 Apr;23(4):358-67. doi: 10.1002/humu.20012. Hum Mutat. 2004. PMID: 15024730

3

APOE promoter, ACE1 and CYP46 polymorphisms and beta-amyloid in Alzheimer's disease.

Chalmers KA, Culpan D, Kehoe PG, Wilcock GK, Hughes A, Love S. Chalmers KA, et al. Neuroreport. 2004 Jan 19;15(1):95-8. doi: 10.1097/00001756-200401190-00019. Neuroreport. 2004. PMID: 15106838

4

Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain.

Blomqvist ME, Chalmers K, Andreasen N, Bogdanovic N, Wilcock GK, Cairns NJ, Feuk L, Brookes AJ, Love S, Blennow K, Kehoe PG, Prince JA. Blomqvist ME, et al. Neurobiol Aging. 2005 Jun;26(6):795-802. doi: 10.1016/j.neurobiolaging.2004.07.011. Neurobiol Aging. 2005. PMID: 15718037 Clinical Trial.

5

Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy.

Miners JS, Van Helmond Z, Chalmers K, Wilcock G, Love S, Kehoe PG. Miners JS, et al. J Neuropathol Exp Neurol. 2006 Oct;65(10):1012-21. doi: 10.1097/01.jnen.0000240463.87886.9a. J Neuropathol Exp Neurol. 2006. PMID: 17021406

6

Neurofibrillary tangles may interfere with Smad 2/3 signaling in neurons.

Chalmers KA, Love S. Chalmers KA, et al. J Neuropathol Exp Neurol. 2007 Feb;66(2):158-67. doi: 10.1097/nen.0b013e3180303b93. J Neuropathol Exp Neurol. 2007. PMID: 17279001

7

Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.

Chalmers KA, Love S. Chalmers KA, et al. J Neuropathol Exp Neurol. 2007 Nov;66(11):1019-26. doi: 10.1097/nen.0b013e31815885ad. J Neuropathol Exp Neurol. 2007. PMID: 17984683

8

Insights into the pathogenesis and pathogenicity of cerebral amyloid angiopathy.

Love S, Miners S, Palmer J, Chalmers K, Kehoe P. Love S, et al. Front Biosci (Landmark Ed). 2009 Jan 1;14(12):4778-92. doi: 10.2741/3567. Front Biosci (Landmark Ed). 2009. PMID: 19273389 Free article. Review.

9

LRP-1 variation is not associated with risk of Alzheimer's disease.

Chalmers KA, Barker R, Passmore PA, Panza F, Seripa D, Solfrizzi V, Love S, Prince JA, Kehoe PG. Chalmers KA, et al. Int J Mol Epidemiol Genet. 2010 Feb 20;1(2):104-13. Int J Mol Epidemiol Genet. 2010. PMID: 21537384 Free PMC article.

10

Distribution of the branched chain aminotransferase proteins in the human brain and their role in glutamate regulation.

Hull J, Hindy ME, Kehoe PG, Chalmers K, Love S, Conway ME. Hull J, et al. J Neurochem. 2012 Dec;123(6):997-1009. doi: 10.1111/jnc.12044. Epub 2012 Nov 1. J Neurochem. 2012. PMID: 23043456 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters